|Media > LSD and Psilocybin
December 17, 2009
Eighth Subject Enrolled in LSD Trial
The eighth subject has been enrolled in the MAPS-sponsored clinical trial evaluating LSD to alleviate anxiety associated with a life-threatening illness. The subject has completed the screening process and will be given an experimental LSD session in the coming weeks. Principal investigator Peter Gasser, M.D, is leading the study.
Back to LSD and Psilocybin Research